Health Care & Life Sciences » Biotechnology | Cancer Genetics Inc.

Cancer Genetics Inc.

Cancer Genetics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.68
Market Cap
$9.83 M
Shares Outstanding
57.82 M
Public Float
33.73 M

Profile

Address
Meadows Office Complex
Rutherford New Jersey 07070
United States
Employees -
Website http://www.cancergenetics.com
Updated 07/08/2019
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S.

Financials

View All
Created with Highcharts 5.0.14Cancer Genetics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.12 37212 37216 64216 64220 18420 18415 80315 80320 88020 88020 37320 37320132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14Cancer Genetics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.6 6106 61010 19910 19918 04018 04027 04927 04929 12129 12127 47027 47020132014201520162017201805k10k15k20k25k30k35k

John Pappajohn
Non-Executive Chairman
Raju S. K. Chaganti
Director